Meeting
2024 ASCO Genitourinary Cancers Symposium
Mature results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone.
Authors
Jonathan David Tward
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
Jonathan David Tward , Skyler B Johnson , Kristine E. Kokeny , Shane Lloyd , Donald Maurice Cannon , Christopher B. Dechet , Brock ONeil , Robert A Stephenson , Kenneth M. Boucher , Manish Kohli , Sumati Gupta , Umang Swami , Benjamin L. Maughan , Neeraj Agarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03304418
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 160)
DOI
10.1200/JCO.2024.42.4_suppl.160
Abstract #
160
Poster Bd #
G10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
NRG-GU011: A phase II double-blinded, placebo-controlled trial of prostate oligometastatic radiotherapy with or without androgen deprivation therapy in oligometastatic prostate cancer (NRG PROMETHEAN).
First Author: Bridget F. Koontz
Poster
2020 Genitourinary Cancers Symposium
A phase II, open-label study of durvalumab in combination with stereotactic body radiotherapy in androgen-intact patients with oligometastatic prostate cancer.
First Author: Isobel Porter
Poster
2020 ASCO Virtual Scientific Program
A phase II randomized trial of RAdium-223 dichloride and SABR versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
First Author: Matthew Pierre Deek
Poster
2020 Genitourinary Cancers Symposium
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
First Author: Phuoc T. Tran